Board of Directors

Kurt Azarbarzin, CEO & Founder, SurgiQuest, Inc.
http://www.surgiquest.com
Kurt Azarbarzin founded SurgiQuest, Inc. in spring of 2005 and started operations in April of 2006. He is a senior medical device executive with an accomplished research and development career in the surgical, cardiovascular, interventional, orthopedic and urological markets. Kurt has a proven track record of leading development of over 80 new products, resulting in annual sales of over $910 million. He has demonstrated his marketing acumen, manufacturing expertise, regulatory and clinical knowledge, and an ability to communicate effectively with medical professionals, the financial community and consultants. Mr. Azarbarzin has diversified experience in all facets of product design/enhancement, encompassing process/manufacturing engineering, team building, finance, vendor relations, regulatory requirements and quality assurance. He has successfully built and directed highly technical development teams, including professionals from technicians to PhDs, and managed a myriad of research resources from metallurgy to model shops. Kurt has over 22 years of experience in Marketing, Research & Development and Quality Assurance from U.S. Surgical/Tyco Healthcare, Spine Wave and Respimetrix.

Joseph DeVivo, President, Orthopaedic Reconstruction Division, Smith & Nephew
http://www.smith-nephew.com
Joe DeVivo was appointed President of Smith & Nephew's Orthopaedic Reconstruction Division on June 18, 2007. He brings them 18 years of marketing, development, sales, operations and executive leadership experience. Most recently Joe served as President and Chief Executive Officer of RITA Medical Systems, Inc., a pioneer of radiofrequency ablation technology, which was acquired by AngioDynamics in 2006. Previously, he served as President and Chief Operating Officer of medical robotics company Computer Motion, Inc., helping to turn the company's performance around ahead of its merger with Intuitive Surgery, Inc in 2003. From 1993 to 2002, DeVivo was at United States Surgical (USS), a division of Tyco Healthcare, where he held a wide variety of roles, including Vice President and General Manager of the USS/DG Sutures division, VP of Global Marketing, VP of Global R&D and Director of Product Development. He has a B.S. in Marketing and Management from the University of Richmond.

John F. Feilders, PhD, Venture Partner, CMEA Capital 
http://www.cmea.com
John is an advisor to medical device and investment firms based on over 20 years of management in international biomedical and financial industries. He resides with his family in San Francisco, has lived and worked extensively in Europe and Canada, and managed medical device company operations worldwide. Currently, he represents CMEA Capital on the boards of device companies, Baxano, and SurgiQuest. John is also on the western region board of MedShare, providing surplus medical supplies to hospitals in developing countries; and he assists the Chancellor at UCSF in developing a R&D private-public partnership to enhance drug discovery. Previously, focused on worldwide business development and sales distribution, he was part of the executive teams that co-built NYSE-listed Biomatrix (sold to Genzyme), TSE-listed OrthoSoft (sold to Zimmer), and Praxim, France. Formerly, John was a senior vice president at Merrill Lynch, and his PhD is from Stanford University.

Carter McNabb, Managing Director, River Cities Capital Funds
http://www.rccf.com
Carter McNabb joined River Cities Capital Funds in 1999 and leads the firm’s healthcare investing practice with concentration on medical device and technology-enabled healthcare service companies. Previously, Carter worked in marketing and business development for Home Technology Healthcare, a comprehensive home healthcare company offering nursing, DME, infusion therapy and hospice across the southeast. Home Technology Healthcare was private equity financed by Willis Stein & Co. and acquired by Integrated Health Services in 1997. Carter worked in equity research at J.C. Bradford & Co. (now part of UBS) while attending business school at Vanderbilt University. He is a graduate of Trinity College in Hartford, CT. Carter has led over 14 healthcare investments for River Cities during his tenure and currently serves as Director on the boards of OrthoHelix Surgical Designs, OrthoScan, Nico Neuro, Health Integrated, AcceleCare Wound Centers, and SurgiQuest.

Ned Scheetz, Founder, Aphelion Capital, LLC
http://www.aphelioncapital.net
Ned Scheetz is the founder of Aphelion Capital, a healthcare investment firm engaged in public and private equity investing. Prior to forming Aphelion, Ned was a Managing Director with Piper Jaffray Ventures (“PJV”) for seven years. Ned joined PJV from Janus Capital where he was a Senior Research Analyst covering healthcare. Ned is currently a Director of Thermics Inc., SurgiQuest, Inc., and Vaso Nova and Chairman of Vitruvian Orthopaedics, and has served on the boards of 14 healthcare companies in his career. He holds the CFA designation and is an Advisory Board Member with the Center for Medical Device Innovation and on the Business Advisory Board of The Epilepsy Therapy Development Project. Ned received his MBA from Duke University and his BA from Colby College.

Bruce Shook, President & CEO of Neuronetics
http://www.neuronetics.com
Bruce Shook is the President and CEO of Neuronetics in Malvern, PA. Neuronetics is a clinical stage medical device company developing novel therapeutic products for psychiatric and neurologic diseases. Neuronetics was created around non-invasive brain stimulation technology licensed from The Innovation Factory and Emory University. Previously, Bruce was President and CEO of Neuron Therapeutics, a venture-backed company developing drug/device combination products for the treatment of traumatic CNS disorders. He co-founded Neuron Therapeutics with scientific staff from Thomas Jefferson University. Prior to Neuron Therapeutics, Mr. Shook was President of Abiomed, a publicly traded manufacturer of advanced cardiac assist technology, where he brought the first external ventricular assist device to the U.S. market and was responsible for sales, marketing, engineering, manufacturing, regulatory affairs and quality assurance. He has also held positions in engineering, sales support and regulatory affairs with Cordis Corporation. Bruce has more than 20 years of experience in the medical device industry including venture finance of early stage companies. He holds advanced degrees in biomedical engineering and business administration from Columbia University and the MIT Sloan School of Management, respectively. He is a Director for Neuronetics, Cardiac Concepts (a venture-backed medtech company) and the Penn State Research Foundation.